文献速递肿瘤 PET/CT放射性药物与辐射防护

在健康受试者中利用动态FDG-PET/MRI评估肾功能参数肾小球滤过率和有效肾血浆流量

Assessing the kidney function parameters glomerular filtration rate and effective renal plasma flow with dynamic FDG-PET/MRI in healthy subjects.
PubMed 文献 · EJNMMI Res · 2018-05-09

该研究前瞻性纳入24名健康成人,行动态同步PET/MRI检查,基于FDG在肾脏的浓度行为,用Patlak分析估算肾小球滤过率(GFR)、基于积分估算有效肾血浆流量(ERPF),并与静脉血样参考值比较。结果显示PET/MRI估算的总肾GFR和ERPF与参考值高度相关(r=0.88/p<0.0001和r=0.82/p<0.0001),均值间无显著差异。结论为这是GFR和ERPF可用动态FDG PET/MRI在健康肾脏中评估的概念验证,对接受常规扫描的患者可避免额外肾功能检查,尚需进一步研究将该PET/MRI方法转化至PET/CT应用。

要点

  • 24名健康成人前瞻性行动态同步PET/MRI,用Patlak分析估算GFR、基于积分估算ERPF。
  • PET/MRI估算的总肾GFR与参考值高度相关(r=0.88/p<0.0001),均值间无显著差异。
  • PET/MRI估算的总肾ERPF与参考值高度相关(r=0.82/p<0.0001),均值间无显著差异。

核心结论

  • 该研究为概念验证,表明动态FDG PET/MRI可在健康肾脏中评估GFR和ERPF。
  • 对接受常规扫描的患者,该方法可避免额外的肾功能检查。
  • 尚需进一步研究将该PET/MRI方法转化至PET/CT应用。

研究设计与样本

  • 前瞻性研究,纳入24名健康成人受试者,行动态同步PET/MRI检查。
  • 从动态PET序列在MR信息引导下获取时间活度曲线(TAC)。
  • 用Patlak分析确定GFR,基于积分计算ERPF,并与个体内静脉血样参考值比较。

主要发现

  • PET/MRI估算的总肾GFR与参考值高度相关,r=0.88/p<0.0001,均值间无显著差异。
  • PET/MRI估算的总肾ERPF与参考值高度相关,r=0.82/p<0.0001,均值间无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出,尚需进一步研究将该PET/MRI方法转化至PET/CT应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A method was developed to assess the kidney parameters glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) from 2-deoxy-2-[18F]fluoro-D-glucose (FDG) concentration behavior in kidneys, measured with positron emission tomography (PET) scans. Twenty-four healthy adult subjects prospectively underwent dynamic simultaneous PET/magnetic resonance imaging (MRI) examination. Time activity curves (TACs) were obtained from the dynamic PET series, with the guidance of MR information. Patlak analysis was performed to determine the GFR, and based on integrals, ERPF was calculated. Results were compared to intra-individually obtained reference values determined from venous blood samples. RESULTS: Total kidney GFR and ERPF as estimated by dynamic PET/MRI were highly correlated to their reference values (r = 0.88/p < 0.0001 and r = 0.82/p < 0.0001, respectively) with no significant difference between their means. CONCLUSIONS: The study is a proof of concept that GFR and ERPF can be assessed with dynamic FDG PET/MRI scans in healthy kidneys. This has advantages for patients getting a routine scan, where additional examinations for kidney function estimation could be avoided. Further studies are required for transferring this PET/MRI method to PET/CT applications.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Geist BK, Baltzer P, Fueger B, et al. Assessing the kidney function parameters glomerular filtration rate and effective renal plasma flow with dynamic FDG-PET/MRI in healthy subjects. EJNMMI Res. 2018. PMID: 29744748. doi:10.1186/s13550-018-0389-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。